TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study.

Marina C Garassino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.